The global bone grafts and substitutes market size was estimated to be US$ 2.95 billion in 2021 and is expected to grow at a CAGR of 6.3% between 2023 to 2032.
The usage of bone transplants in orthopedic operations is routine. These procedures are considered as elective surgeries, and during the COVID-19 epidemic, the bulk of elective surgeries were delayed or cancelled. As a result, the need for orthopedic surgery equipment, such as bone grafts and substitutes, greatly reduced. Furthermore, the production of the devices was slowed down by lengthy factory closures by market players in several countries.
Manufacturers of bone grafts and substitutes are banking on profitable prospects as the incidences of osteoporosis in the world's population rises. Osteoporosis is more prevalent in women. On the backdrop of ongoing advancements in orthopedic operations, the market for bone grafts and substitutes has opened brand-new doors.
Over the course of the forecast period, the market for bone grafts and substitutes is predicted to be influenced by the increased demand for dental bone grafts. High prices are believed to represent a major impediment to industry expansion. Players in the market are concentrating on providing low - cost solutions to satisfy patients' growing needs for bone grafts and substitutes.
In the coming years, the global market is anticipated to be influenced by technological advancements in the creation of superior bone grafts. The significant causes driving demand in the global market for bone grafts and substitutes is the focus on treating fractures to the bones and joints. The discovery of several biological products, including autologous, allogenic, and synthetic bone grafts for generation, has fundamentally altered the way that fracture treatment is administered in the modern world and how bone loss is treated.
Bone Grafts and Substitutes Market Share Analysis, by Geography (2022)
The explosive growth of COVID-19 around the world has an adverse effect on the global market for bone transplants and alternatives. Long-term lockdown and a spike in the number of coronavirus patients put a great deal of strain on the healthcare system. The majority of elective surgery were delayed or cancelled because of the pandemic. This has resulted in a drop in the demand for orthopedic surgical equipment, such as bone grafts and substitutes.
The major players covered in the bone grafts and substitutes market report are AlloSource, Baxter, Johnson & Johnson Services Inc., Smith & Nephew, Stryker, Orthofix Medical Inc., Zimmer Biomet, Medtronic, Geistlich Pharma AG, Dentsply Sirona, Biobank, Wright Medical Group N.V., Globus Medical, BioHorizons, Integra LifeSciences, Arthrex Inc., Artoss Inc., ACE Surgical Supply Co. Inc., ACE Surgical Supply Co. Inc., Institut Straumann AG, NuVasive Inc. and others.
Market Segmentation:
By Product Type
By Application
By End User Segment
By Geography
The global market for bone grafts and substitutes will most likely expand at over 6.3% CAGR from 2023 to 2032.
The bone graft & substitutes market size was estimated at $2.95 bn in 2021.
The significant causes driving demand in the global market for bone grafts and substitutes is the focus on treating fractures to the bones and joints.
With a market share of more than 40% of global sales in 2021, North America dominated the bone graft and substitute industry. The main factors influencing the regional market growth are rising awareness of novel goods that are commercially available and proximity to a fully advanced healthcare system.
The end-use segments in bone grafts and substitutes market are Hospitals, Specialty clinics and Others.
Major players operating in the global bone grafts and substitutes market include AlloSource, Baxter, Johnson & Johnson Services Inc., Smith & Nephew, Stryker, Orthofix Medical Inc., Zimmer Biomet, Medtronic, Geistlich Pharma AG, Dentsply Sirona, Biobank, Wright Medical Group N.V., Globus Medical, BioHorizons, Integra LifeSciences, Arthrex Inc., Artoss Inc., ACE Surgical Supply Co. Inc., ACE Surgical Supply Co. Inc., Institut Straumann AG, NuVasive Inc. and others.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved